“…Trifluoromethyl-containing heterocycles have received increasing attention due to their wide prevalence in natural products, pharmaceuticals, agrochemicals, functional materials, and biologically active molecules. 1 It is well-known that the incorporation of a trifluoromethyl group into organic scaffolds could improve the physicochemical and pharmacokinetic properties and modulate p K a and lipophilicity of the parent molecules. 2 Notably, approximately 25% of marketed drugs and 30% of agrochemical products contain at least one fluorine or trifluoromethyl moiety, such as mavacoxib, efavirenz, melatonin, sitagliptin, pentoxifylline, and so on (Fig.…”